Brandon Capital invests in the most promising biomedical opportunities that have the potential to improve the lives of patients

From early-stage seed investment through to expansion capital, we are able to support life science companies from proof-of-concept through to commercialisation.


Recognising the effort required to commercialise a great idea, we partner with entrepreneurs for the long-haul, working collaboratively with them to support the development and commercialisation of their technology, thereby creating value for their teams, our investors and ultimately benefiting patients.

We like to invest early - we have been the founding investor for most of our current portfolio companies